United States of America v. INSYS Therapeutics, Inc.

Good Law
United States District Court, Central District of CaliforniaApril 19, 20212:16-cv-07937California5,807 words

Opinion

trial_court Opinion

UNITED STATES DISTRICT COURT

1

CENTRAL DISTRICT OF CALIFORNIA

2 3 UNITED STATES OF AMERICA ex rel. CASE NO. (ASx) 4 MELINA EBU-ISAAC and the States of 2:16-cv-07937-JLS-AJW 5 CALIFORNIA, COLORADO, CONNECTICUT,

DELAWARE, FLORIDA, GEORGIA, HAWAII,

6

ILLINOIS, INDIANA, IOWA, LOUISIANA,

7 MASSACHUSETTS, MICHIGAN, Hon. Josephine L. Staton

MINNESOTA, MONTANA, NEVADA, NEW

8

MEXICO, NEW YORK, NORTH CAROLINA,

9 OKLAHOMA, RHODE ISLAND, 10 TENNESSEE, TEXAS, VERMONT, PROTECTIVE ORDER VIRGINIA, WASHINGTON, the CITY OF 11 CHICAGO and the DISTRICT OF COLUMBIA, 12 13 Relator-Plaintiff, 14 v. 15 16 INSYS THERAPEUTICS, INC. and LINDEN

CARE, LLC, LINDEN CARE, INC., LINDEN

17

CARE HOLDINGS, INC., BELHEALTH

18 INVESTMENT PARTNERS, LLC, BEHEALTH 19 INVESTMENT MANAGEMENT, LLC, and

BELHEALTH INVESTMENT FUND, LP

20 21 Defendants. 22 23 1. A. PURPOSES AND LIMITATIONS 24 Discovery in this action is likely to involve production of confidential, 25 proprietary, or private information for which special protection from public 26 disclosure and from use…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.